Virtual Medicinal Product (VMP) - Amiloride 10mg/5ml / Furosemide 125mg/5ml oral suspension
Name Details
Name | Start Date | End Date | |
---|---|---|---|
Name | Current Name Amiloride 10mg/5ml / Furosemide 125mg/5ml oral suspension | Start Date 14-12-2010 | End Date |
Previous Name | Previous Name Co-amilofruse 10mg/125mg/5ml oral suspension | Start Date 15-08-2007 |
End Date
|
Unit Dose & Form Information
- DF Indicator
- Continuous
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral suspension
- Ontology Form/Route
- suspension.oral
- Name Basis
- Other
Codes
- ATC Code
- C03EB01
- BNF Codes
-
- BNF code 02020400
Code | Start Date | End Date |
---|---|---|
11814611000001104 | 15-08-2007 |
VMP Ingredients
Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
---|---|---|---|---|
Amiloride hydrochloride | Based on Ingredient Substance | 2 mg | 1 ml | |
Furosemide | Based on Ingredient Substance | 25 mg | 1 ml |
Name
Amiloride hydrochloride
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
2.0
Strength and UOM (Dmr)
1.0
Name
Furosemide
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
25.0
Strength and UOM (Dmr)
1.0
Parent Products
-
VTMAmiloride + Furosemide
-
VMP(Current) Amiloride 10mg/5ml / Furosemide 125m...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
---|---|---|
1 ml |